Skhynix Inc.

Je Il Pharmaceutical Co., Ltd.

Eun Seon Kim

Hyunho Lee

Jin Ha Kim

Jung Won Seo

Kwangwoo Chun

Bo-Young Joe

Hyeongchan Oh

Eun Sung Jang

Jeong-Min Kim

Jiseon Park

Hanchang Lee

The present invention relates to novel tricyclic derivative compounds, and more specifically to tricyclic derivative compounds, optical isomers thereof, racemates thereof, or pharmaceutically acceptable salts thereof, which have excellent activity against PARP-1, tankyrase-1 or tankyrase-2. The tricyclic derivative compounds, optical isomers thereof, racemates thereof or pharmaceutically acceptable salts thereof according to the present invention have inhibitory activity against PARP-1, tankyrase-1, or tankyrase-2, and thus can be effectively used for the prevention or treatment of neuropathic pain, neurodegenerative diseases, cardiovascular diseases, diabetic neuropathy, inflammatory diseases, osteoporosis, or cancer.

Tricyclic derivative compound, method for preparing same, and pharmaceutical composition comprising same

A semiconductor device includes a data storage layer formed over a semiconductor substrate in which a lower structure is formed, and an electrode structure formed on at least one side of the data storage layer over the semiconductor substrate. The electrode structure includes a metal pattern, and a graphene pattern formed over the metal pattern.

Semiconductor device with electrode structure including graphene pattern formed over metal pattern

Growing community of inventors

Gyeonggi-do, South Korea

Eun Seon Kim